Nothing Special   »   [go: up one dir, main page]
News & Perspective
Drugs & Diseases
CME & Education
Video
Decision Point

Specialty: Multispecialty
Allergy & Immunology
Anesthesiology
Cardiology
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Medicine
Gastroenterology
General Surgery
Hematology - Oncology
HIV/AIDS
Hospital Medicine
Infectious Diseases
Internal Medicine
Multispecialty
Nephrology
Neurology
Ob/Gyn & Women's Health
Oncology
Ophthalmology
Orthopedics
Pathology & Lab Medicine
Pediatrics
Plastic Surgery
Psychiatry
Public Health
Pulmonary Medicine
Radiology
Rheumatology
Transplantation
Urology
Today on Medscape
Business of Medicine
Medical Lifestyle
Science & Technology
Medical Students
Nurses
Pharmacists
Residents
Edition: English

Medscape

English
Deutsch
Español
Français
Português
UKNew

Univadis

Sign Up It's Free!
English Edition

Medscape

Univadis

    X
    Univadis from Medscape

    No Results

      Friday, November 15, 2024
      News & Perspective Drugs & Diseases CME & Education Video Decision Point

      From Medscape Oncology

      Coverage from the

      American Society for Radiation Oncology (ASTRO) 2024 Annual Meeting

      September 29 - October 02, 2024; Washington, DC and Virtual/Online

      September 29 - October 02, 2024 Washington, DC and Virtual/Online

      Conference News

      Medscape Oncology© 

      Popular News From ASTRO 2023

      • Short-Course SBRT: Standard of Care in Prostate Cancer? Short-Course SBRT: Standard of Care in Prostate Cancer? For patients with low and favorable intermediate-risk prostate cancer, stereotactic body radiation therapy delivered in five fractions provided similar 5-year disease control as conventional, higher-dose external-beam radiation.
        Medscape Medical News, Oct 04, 2023
      • DART Can Limit Toxicities in Head, Neck Cancer DART Can Limit Toxicities in Head, Neck Cancer Daily adaptive radiotherapy minimized radiation exposure to salivary glands and led to fewer acute toxicities among patients with head and neck cancer.
        Medscape Medical News, Oct 09, 2023

      Previous Coverage

      Find Us On
      About
      About Medscape Privacy Policy Editorial Policy Cookies Manage Preferences Terms of Use Advertising Policy Help Center
      Membership
      Become a Member About You Professional Information Newsletters & Alerts Market Research
      App
      Medscape
      Editions
      English Deutsch Español Français Português
      All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC. This website also contains material copyrighted by 3rd parties.